Ir.ambrx.com

Ambrx Presents New Preclinical Data on ARX517 and ARX305 at …

WEBSAN DIEGO, April 19, 2023 (GLOBE NEWSWIRE) - Ambrx Biopharma Inc., or Ambrx (NASDAQ: AMAM), announced new preclinical data at the 2023 American Association …

Actived: 5 days ago

URL: https://ir.ambrx.com/news/news-details/2023/Ambrx-Presents-New-Preclinical-Data-on-ARX517-and-ARX305-at-the-2023-AACR-Annual-Meeting/default.aspx

Phase 1 Dose Escalation Study of ARX788, a Next-Generation …

WEBpresented at the 46th annual san antonio breast cancer symposium (sabcs); december 5–9, 2023; san antonio, tx. background results study design

Category:  Cancer Go Health

Ambrx Shareholders Approve Acquisition by Johnson & Johnson

WEBSAN DIEGO, March 06, 2024 (GLOBE NEWSWIRE) - Ambrx Biopharma, Inc., (“Ambrx” or the “Company”) (NASDAQ: AMAM), today announced that its shareholders approved a …

Category:  Health Go Health

Ambrx Appoints Stephen Glover as Chairman of its Board of …

WEBSAN DIEGO, May 18, 2023 (GLOBE NEWSWIRE) - Ambrx Biopharma Inc., or Ambrx (NASDAQ: AMAM), today announced that Stephen Glover has joined the Company’s …

Category:  Health Go Health